The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling

Although vaccines that provide protection against severe illness from coronavirus disease (COVID-19) have been made available, emerging variant strains of severe acute respiratory syndrome 2 coronavirus 2 (SARS-CoV-2) are of concern. A different research direction involves investigation of antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitsillou, Eleni, Liang, Julia, Hung, Andrew, Karagiannis, Tom C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014761/
https://www.ncbi.nlm.nih.gov/pubmed/35462185
http://dx.doi.org/10.1016/j.jmgm.2022.108193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014761/
https://www.ncbi.nlm.nih.gov/pubmed/35462185
http://dx.doi.org/10.1016/j.jmgm.2022.108193

Ejemplares similares